Bristol-Myers Squibb
Senior Director, Market Access Enterprise Accounts
Bristol-Myers Squibb, Minneapolis, Minnesota, United States, 55400
Senior Director, Market Access Enterprise AccountsWorking with UsChallenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams rich in diversity. Take your career farther than you thought possible.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services, and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
Summary:
The BMS Cell Therapy Market Access Team is seeking an experienced Senior Director to lead the successful implementation of BMS Cell Therapy programs within large enterprise accounts across diverse care settings. This role is critical to ensuring that key Cell Therapy ecosystem players (e.g., enterprise accounts, payers, policymakers) understand the value proposition of BMS Cell Therapy to enable broader patient access.
Additionally, a key responsibility is to centralize coordination across enterprise leadership, supply chain, financial services, administrative functions, and support services to optimize patient care, streamline operations, and improve financial efficiency, ensuring effective integration across all departments for enhanced clinical outcomes and operational excellence.
The ideal candidate will have a proven track record in launching cell and gene therapies, display a deep understanding of the complexities within large enterprise accounts, and be an expert in Cell Therapy Market Access dynamics (i.e., policy, reimbursement, pricing, coding). The role requires a strategic leader capable of collaborating with policymakers, payers, and C-suite executives to articulate the value of BMS Cell Therapy and be accountable for the successful setup and implementation of programs within key enterprise accounts.
Responsibilities:
Serve as primary point of contact for BMS Cell Therapy at enterprise accounts to ensure the successful implementation of BMS Cell Therapy programs by delivering CT business reviews with the C-suite level and key decision makers to drive the expansion of community uptake.
Manage and coordinate the complex business matrix within the account (and BMS matrix coordination) to advance the expansion of CAR-T use in the community by driving key decisions and defining foundational processes for all stakeholders.
Lead discussions with the enterprise account stakeholders (C-suite, administrators, key formulary decision-makers, etc.) on strategic priorities, operational challenges, and potential opportunities for collaboration to optimize BMS CAR T therapy implementation and delivery.
Communicate payer coverage within enterprise accounts; educate enterprise account stakeholders around reimbursement, coverage, and coding.
Conduct business to business meetings to educate & elevate the understanding of the complexity and/or new reimbursement methodologies.
Provide ongoing education to key stakeholders within enterprise accounts on payer approval pathways post-BMS Cell Therapy onboarding; provide tools and resources necessary to secure appropriate coverage for BMS CAR Ts.
Drive coordination with cross-functional matrix team to optimize swift patient access within enterprise accounts.
Collaborate closely with Cell Therapy Market Access Manager (CMAM) leadership to ensure alignment in execution between enterprise and across accounts.
Maintain a current understanding of the evolving cell and gene therapy landscape to identify trends, risks, and opportunities that impact CAR T therapy integration at enterprise accounts, particularly around reimbursement methodologies.
Identify gaps / pain points within enterprise account ecosystem, recognize key levers for optimizing care delivery, develop solutions that align with stakeholder needs, and orchestrate cross-functional matrix for implementation.
Identify and define opportunities to improve the enterprise account onboarding process to bolster pull-through of account and coordinate with CTAM, CMAM and/or Medical partners on execution.
Qualifications:
Bachelor’s and 12+ years of experience.
Master’s degree in health policy, business administration, or a similar discipline preferred.
Minimum of 10 years of experience in healthcare policy, reimbursement, and payer relations.
Proven experience leading payer and reimbursement teams, including developing and executing reimbursement strategies (Cell or Gene Therapy preferred).
Experience launching cell and gene therapies, specifically within Medicare Part A and Part B, with a strong track record of success preferred.
Excellent interpersonal / relationship management skills, oral and written communication, and outstanding presentation skills with a demonstrated history of engaging with C-suite executives.
Robust project management skills, ability to multi-task and deliver on objectives across multiple customers in tight timelines.
Ability to travel 40-50% of the time with overnight.
#J-18808-Ljbffr
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services, and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
Summary:
The BMS Cell Therapy Market Access Team is seeking an experienced Senior Director to lead the successful implementation of BMS Cell Therapy programs within large enterprise accounts across diverse care settings. This role is critical to ensuring that key Cell Therapy ecosystem players (e.g., enterprise accounts, payers, policymakers) understand the value proposition of BMS Cell Therapy to enable broader patient access.
Additionally, a key responsibility is to centralize coordination across enterprise leadership, supply chain, financial services, administrative functions, and support services to optimize patient care, streamline operations, and improve financial efficiency, ensuring effective integration across all departments for enhanced clinical outcomes and operational excellence.
The ideal candidate will have a proven track record in launching cell and gene therapies, display a deep understanding of the complexities within large enterprise accounts, and be an expert in Cell Therapy Market Access dynamics (i.e., policy, reimbursement, pricing, coding). The role requires a strategic leader capable of collaborating with policymakers, payers, and C-suite executives to articulate the value of BMS Cell Therapy and be accountable for the successful setup and implementation of programs within key enterprise accounts.
Responsibilities:
Serve as primary point of contact for BMS Cell Therapy at enterprise accounts to ensure the successful implementation of BMS Cell Therapy programs by delivering CT business reviews with the C-suite level and key decision makers to drive the expansion of community uptake.
Manage and coordinate the complex business matrix within the account (and BMS matrix coordination) to advance the expansion of CAR-T use in the community by driving key decisions and defining foundational processes for all stakeholders.
Lead discussions with the enterprise account stakeholders (C-suite, administrators, key formulary decision-makers, etc.) on strategic priorities, operational challenges, and potential opportunities for collaboration to optimize BMS CAR T therapy implementation and delivery.
Communicate payer coverage within enterprise accounts; educate enterprise account stakeholders around reimbursement, coverage, and coding.
Conduct business to business meetings to educate & elevate the understanding of the complexity and/or new reimbursement methodologies.
Provide ongoing education to key stakeholders within enterprise accounts on payer approval pathways post-BMS Cell Therapy onboarding; provide tools and resources necessary to secure appropriate coverage for BMS CAR Ts.
Drive coordination with cross-functional matrix team to optimize swift patient access within enterprise accounts.
Collaborate closely with Cell Therapy Market Access Manager (CMAM) leadership to ensure alignment in execution between enterprise and across accounts.
Maintain a current understanding of the evolving cell and gene therapy landscape to identify trends, risks, and opportunities that impact CAR T therapy integration at enterprise accounts, particularly around reimbursement methodologies.
Identify gaps / pain points within enterprise account ecosystem, recognize key levers for optimizing care delivery, develop solutions that align with stakeholder needs, and orchestrate cross-functional matrix for implementation.
Identify and define opportunities to improve the enterprise account onboarding process to bolster pull-through of account and coordinate with CTAM, CMAM and/or Medical partners on execution.
Qualifications:
Bachelor’s and 12+ years of experience.
Master’s degree in health policy, business administration, or a similar discipline preferred.
Minimum of 10 years of experience in healthcare policy, reimbursement, and payer relations.
Proven experience leading payer and reimbursement teams, including developing and executing reimbursement strategies (Cell or Gene Therapy preferred).
Experience launching cell and gene therapies, specifically within Medicare Part A and Part B, with a strong track record of success preferred.
Excellent interpersonal / relationship management skills, oral and written communication, and outstanding presentation skills with a demonstrated history of engaging with C-suite executives.
Robust project management skills, ability to multi-task and deliver on objectives across multiple customers in tight timelines.
Ability to travel 40-50% of the time with overnight.
#J-18808-Ljbffr